Activation of the extracellular calcium-sensing receptor initiates insulin secretion from human islets of Langerhans: involvement of protein kinases

J Endocrinol. 2006 Sep;190(3):703-10. doi: 10.1677/joe.1.06891.

Abstract

The extracellular calcium-sensing receptor (CaR) is usually associated with systemic Ca(2+) homeostasis, but the CaR is also expressed in many other tissues, including pancreatic islets of Langerhans. In the present study, we have used human islets and an insulin-secreting cell line (MIN6) to investigate the effects of CaR activation using the calcimimetic R-568, a CaR agonist that activates the CaR at physiological concentrations of extracellular Ca(2+). CaR activation initiated a marked but transient insulin secretory response from both human islets and MIN6 cells at a sub-stimulatory concentration of glucose, and further enhanced glucose-induced insulin secretion. CaR-induced insulin secretion was reduced by inhibitors of phospholipase C or calcium-calmodulin-dependent kinases, but not by a protein kinase C inhibitor. CaR activation was also associated with an activation of p42/44 mitogen-activated protein kinases (MAPK), and CaR-induced insulin secretion was reduced by an inhibitor of p42/44 MAPK activation. We suggest that the beta-cell CaR is activated by divalent cations co-released with insulin, and that this may be an important mechanism of intra-islet communication between beta-cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aniline Compounds / pharmacology*
  • Antibodies, Monoclonal / pharmacology
  • Benzylamines / pharmacology
  • Calcium / metabolism
  • Calcium / pharmacology
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Carbazoles / pharmacology
  • Cell Communication
  • Cell Line
  • Cells, Cultured
  • Estrenes / pharmacology
  • Extracellular Fluid / metabolism*
  • Flavonoids / pharmacology
  • Glucose / pharmacology
  • Humans
  • Immunohistochemistry
  • Indoles / pharmacology
  • Insulin / metabolism*
  • Insulin Secretion
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism*
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / immunology
  • Mitogen-Activated Protein Kinases / metabolism
  • Phenethylamines
  • Propylamines
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinases / metabolism*
  • Pyrrolidinones / pharmacology
  • RNA, Messenger / analysis
  • Receptors, Calcium-Sensing / antagonists & inhibitors
  • Receptors, Calcium-Sensing / immunology
  • Receptors, Calcium-Sensing / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Staurosporine / pharmacology
  • Stimulation, Chemical
  • Sulfonamides / pharmacology
  • Type C Phospholipases / antagonists & inhibitors

Substances

  • Aniline Compounds
  • Antibodies, Monoclonal
  • Benzylamines
  • Carbazoles
  • Estrenes
  • Flavonoids
  • Indoles
  • Insulin
  • N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine
  • Phenethylamines
  • Propylamines
  • Pyrrolidinones
  • RNA, Messenger
  • Receptors, Calcium-Sensing
  • Sulfonamides
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Go 6976
  • KN 93
  • Protein Kinases
  • Protein Kinase C
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Mitogen-Activated Protein Kinases
  • Type C Phospholipases
  • Staurosporine
  • Glucose
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Calcium